JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

<p>In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00272" target="_blank" rel="noopener">Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study</a>" by Bourhis, et al published September 03, 2025</p> <p><span style= "text-decoration: underline;"><strong>TRANSCRIPT</strong></span></p> <p> </p>